Development and Validation of Targeted Next-Generation Sequencing Panels for Detection of Germline Variants in Inherited Diseases

被引：20
|
作者：
Santani, Avni [1 ,2 ]
Murrell, Jill [2 ]
Funke, Birgit [3 ,4 ]
Yu, Zhenming [2 ]
Hegde, Madhuri [5 ]
Mao, Rong [6 ]
Ferreira-Gonzalez, Andrea [8 ]
Voelkerding, Karl V. [7 ,9 ]
Weck, Karen E. [10 ,11 ]
机构：
[1] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Genom Diagnost, Philadelphia, PA 19104 USA
[3] MGH Harvard Med Sch, Dept Pathol, Boston, MA USA
[4] Lab Mol Med Partners HealthCare Personalized Med, Cambridge, MA USA
[5] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA
[6] Univ Utah, Sch Med, Dept Pathol, ARUP Labs,Inst Clin & Expt Pathol, Salt Lake City, UT USA
[7] Univ Utah, Dept Pathol, Sch Med, Salt Lake City, UT USA
[8] Virginia Commonwealth Univ, Dept Pathol, Div Mol Diagnost, Richmond, VA USA
[9] ARUP Labs, Genom & Bioinformat, Salt Lake City, UT USA
[10] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA
[11] Univ N Carolina, Lab Med & Genet, Chapel Hill, NC USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2017年 / 141卷 / 06期
关键词：
LABORATORY STANDARDS; MOLECULAR PATHOLOGY; CLINICAL GENOMICS; GUIDELINES; MANAGEMENT; RESOURCE; COLLEGE; QUALITY; TESTS; SNP;
D O I：
10.5858/arpa.2016-0517-RA
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Context.-The number of targeted next-generation sequencing (NGS) panels for genetic diseases offered by clinical laboratories is rapidly increasing. Before an NGS-based test is implemented in a clinical laboratory, appropriate validation studies are needed to determine the performance characteristics of the test. Objective.-To provide examples of assay design and validation of targeted NGS gene panels for the detection of germline variants associated with inherited disorders. Data Sources.-The approaches used by 2 clinical laboratories for the development and validation of targeted NGS gene panels are described. Important design and validation considerations are examined. Conclusions.-Clinical laboratories must validate performance specifications of each test prior to implementation. Test design specifications and validation data are provided, outlining important steps in validation of targeted NGS panels by clinical diagnostic laboratories.
引用
收藏
页码：787 / 797
页数：11
相关论文
共 50 条
  • [41] Validation of a Comprehensive, Targeted Next-Generation Sequencing Panel for Solid Tumors
    Barrie, E.
    Yu, X.
    Sabato-Charreun, F.
    Olson, T.
    Ganesh, V.
    Williamson, V.
    Bullard, B.
    Gonzalez, I.
    Barrick, B.
    Paulraj, P.
    Turner, S.
    Ferreira-Gonzalez, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S62 - S63
  • [42] Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas
    Racu, Marie-Lucie
    Schiavo, Andrea Alex
    Van Campenhout, Claude
    De Neve, Nancy
    Masuy, Thomas
    Maris, Calliope
    Decaestecker, Christine
    Remmelink, Myriam
    Salmon, Isabelle
    D'Haene, Nicky
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2024, 139
  • [43] Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies
    Artymiuk, Cody J.
    Basu, Shubham
    Koganti, Tejaswi
    Tandale, Pratyush
    Balan, Jagadheshwar
    Dina, Michelle A.
    Fritcher, Emily G. Barr
    Wu, Xianglin
    Ashworth, Taylor
    He, Rong
    Viswanatha, David S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (07): : 583 - 598
  • [44] Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases
    Liu, Yanqiu
    Wei, Xiaoming
    Kong, Xiangdong
    Guo, Xueqin
    Sun, Yan
    Man, Jianfen
    Du, Lique
    Zhu, Hui
    Qu, Zelan
    Tian, Ping
    Mao, Bing
    Yang, Yun
    PLOS ONE, 2015, 10 (08):
  • [45] Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing
    Rosenthal, Sun Hee
    Sun, Weimin
    Zhang, Ke
    Liu, Yan
    Nguyen, Quoclinh
    Gerasimova, Anna
    Nery, Camille
    Cheng, Linda
    Castonguay, Carolyn
    Hiller, Elaine
    Li, James
    Elzinga, Christopher
    Wolfson, David
    Smolgovsky, Alla
    Chen, Rebecca
    Buller-Burckle, Arlene
    Catanese, Joseph
    Grupe, Andrew
    Lacbawan, Felicitas
    Owen, Renius
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [46] Algorithmic improvements for discovery of germline copy number variants in next-generation sequencing data
    Brendan O’Fallon
    Jacob Durtschi
    Ana Kellogg
    Tracey Lewis
    Devin Close
    Hunter Best
    BMC Bioinformatics, 23
  • [47] Clinically Relevant Germline Variants Detected by Next-Generation Sequencing in Children With Hematological Malignancies
    Nasedkina, T.
    Semenova, V.
    Lisitsa, T.
    Zhukovskaya, E.
    Kasatkin, V.
    Karelin, A.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S356 - S356
  • [48] Algorithmic improvements for discovery of germline copy number variants in next-generation sequencing data
    O'Fallon, Brendan
    Durtschi, Jacob
    Kellogg, Ana
    Lewis, Tracey
    Close, Devin
    Best, Hunter
    BMC BIOINFORMATICS, 2022, 23 (01)
  • [49] Next-generation sequencing identifies multiple disease associated variants in inherited heart conditions
    Gerull, B.
    Kuriachan, V.
    Clegg, R.
    Exner, D.
    Ferrier, R.
    Desmarais, S.
    Gordon, P.
    Duff, H.
    EUROPEAN HEART JOURNAL, 2013, 34 : 421 - 421
  • [50] Onco-Somatik: A Mixed Model Approach for the Detection of Somatic Variants in Targeted Next-Generation Sequencing
    Williamson, V. S.
    Gadepalli, V. S.
    Kusmerik, A.
    Popa, A.
    Ren, R.
    SabatoCharreun, M.
    Vlangos, C. N.
    Ferreira-Gonzalez, A.
    Dumur, C. I.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 993 - 993
12345